Clarification sought from Ajanta Pharma Ltd

| Updated on February 01, 2018 Published on January 24, 2017

The Exchange has sought clarification from Ajanta Pharma Ltd on January 24, 2017 with reference to news flashed on ET Now dated January 24, 2016. "Ajanta Pharma gets import alert from USFDA for its Paithan unit at Aurangabad."

The reply is awaited.

Source : BSE - www.bseindia.com

Published on January 24, 2017
This article is closed for comments.
Please Email the Editor